• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 受体基因多态性及其生物学效应与非酒精性脂肪性肝病的发生发展

Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Medical School, University of Patras, University Hospital of Patras, Rion, 26504 Patras, Greece.

Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, 26504 Patras, Greece.

出版信息

Int J Mol Sci. 2023 May 5;24(9):8288. doi: 10.3390/ijms24098288.

DOI:10.3390/ijms24098288
PMID:37175993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10179740/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with increasing prevalence worldwide. The genetic and molecular background of NAFLD pathogenesis is not yet clear. The vitamin D/vitamin D receptor (VDR) axis is significantly associated with the development and progression of NAFLD. Gene polymorphisms may influence the regulation of the VDR gene, although their biological significance remains to be elucidated. VDR gene polymorphisms are associated with the presence and severity of NAFLD, as they may influence the regulation of adipose tissue activity, fibrosis, and hepatocellular carcinoma (HCC) development. Vitamin D binds to the hepatic VDR to exert its biological functions, either by activating VDR transcriptional activity to regulate gene expression associated with inflammation and fibrosis or by inducing intracellular signal transduction through VDR-mediated activation of Ca channels. VDR activity has protective and detrimental effects on hepatic steatosis, a characteristic feature of NAFLD. Vitamin D-VDR signaling may control the progression of NAFLD by regulating immune responses, lipotoxicity, and fibrogenesis. Elucidation of the genetic and molecular background of VDR in the pathophysiology of NAFLD will provide new therapeutic targets for this disease through the development of VDR agonists, which already showed promising results in vivo.

摘要

非酒精性脂肪性肝病 (NAFLD) 是最常见的慢性肝病,全球患病率呈上升趋势。NAFLD 发病机制的遗传和分子背景尚不清楚。维生素 D/维生素 D 受体 (VDR) 轴与 NAFLD 的发生和发展显著相关。基因多态性可能影响 VDR 基因的调控,尽管其生物学意义仍有待阐明。VDR 基因多态性与 NAFLD 的存在和严重程度相关,因为它们可能影响脂肪组织活性、纤维化和肝细胞癌 (HCC) 发展的调节。维生素 D 与肝脏 VDR 结合发挥其生物学功能,通过激活 VDR 转录活性来调节与炎症和纤维化相关的基因表达,或通过 VDR 介导的 Ca 通道激活诱导细胞内信号转导。VDR 活性对非酒精性脂肪性肝病的特征性特征——肝脂肪变性具有保护和有害作用。维生素 D-VDR 信号可能通过调节免疫反应、脂毒性和纤维化来控制 NAFLD 的进展。阐明 VDR 在 NAFLD 病理生理学中的遗传和分子背景将通过开发 VDR 激动剂为这种疾病提供新的治疗靶点,VDR 激动剂在体内已显示出有希望的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/10179740/2e1161072c77/ijms-24-08288-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/10179740/4064b011b3e0/ijms-24-08288-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/10179740/2e1161072c77/ijms-24-08288-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/10179740/4064b011b3e0/ijms-24-08288-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/10179740/2e1161072c77/ijms-24-08288-g002.jpg

相似文献

1
Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression.维生素 D 受体基因多态性及其生物学效应与非酒精性脂肪性肝病的发生发展
Int J Mol Sci. 2023 May 5;24(9):8288. doi: 10.3390/ijms24098288.
2
Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.维生素 D 受体靶向肝细胞核因子 4α 并介导维生素 D 在非酒精性脂肪性肝病中的保护作用。
J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12.
3
Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study.维生素 D 水平和维生素 D 受体基因变异与非酒精性脂肪性肝病的风险相关:一项病例对照研究。
Front Endocrinol (Lausanne). 2021 Aug 6;12:648844. doi: 10.3389/fendo.2021.648844. eCollection 2021.
4
Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.维生素 D 通过受体依赖和非依赖途径拮抗人肝星状细胞中的纤维生成 TGF-β 信号传导。
Gut. 2015 May;64(5):791-9. doi: 10.1136/gutjnl-2014-307024. Epub 2014 Aug 18.
5
Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.维生素 D 受体在肝巨噬细胞中的激活可改善小鼠的肝炎症、脂肪变性和胰岛素抵抗。
Hepatology. 2020 May;71(5):1559-1574. doi: 10.1002/hep.30937. Epub 2020 Feb 23.
6
Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.肝细胞维生素 D 受体调节脂代谢并介导实验性饮食诱导的脂肪变性。
J Hepatol. 2016 Oct;65(4):748-757. doi: 10.1016/j.jhep.2016.05.031. Epub 2016 May 28.
7
Vitamin D and nonalcoholic fatty liver disease.维生素 D 与非酒精性脂肪性肝病。
Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):449-458. doi: 10.1097/MCO.0000000000000605.
8
Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease.维生素 D/维生素 D 受体通路在非酒精性脂肪性肝病中的作用。
Expert Opin Ther Targets. 2023 Jul-Dec;27(11):1145-1157. doi: 10.1080/14728222.2023.2274099. Epub 2023 Dec 7.
9
Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.肥胖症中肝脏与全身血管生成素样蛋白3、肝脏维生素D受体表达与非酒精性脂肪性肝病之间的关系
Liver Int. 2020 Sep;40(9):2139-2147. doi: 10.1111/liv.14554. Epub 2020 Jun 28.
10
Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.维生素 D 水平及维生素 D 相关基因多态性与经肝活检证实的非酒精性脂肪性肝病患者肝纤维化的关系。
Dig Liver Dis. 2019 Jul;51(7):1036-1042. doi: 10.1016/j.dld.2018.12.022. Epub 2019 Jan 9.

引用本文的文献

1
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease.释放治疗潜力:探索新兴核受体之间的相互作用以对抗脂肪性肝病中的代谢功能障碍。
NPJ Metab Health Dis. 2024 Jul 3;2(1):13. doi: 10.1038/s44324-024-00013-6.
2
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency.肝脏和脂肪组织在肝脏疾病发病中的相互作用:探讨维生素缺乏的作用。
Cells. 2024 Sep 30;13(19):1631. doi: 10.3390/cells13191631.
3
Confronting the global obesity epidemic: investigating the role and underlying mechanisms of vitamin D in metabolic syndrome management.

本文引用的文献

1
Wnt/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases.Wnt/β-catenin 信号通路及其在非酒精性脂肪性肝病中的调节剂。
Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):333-345. doi: 10.1016/j.hbpd.2022.10.003. Epub 2022 Oct 20.
2
Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease.血清 25-羟维生素 D 水平较高与美国非酒精性脂肪性肝病患者全因和心血管死亡率降低相关。
Nutrients. 2022 Sep 27;14(19):4013. doi: 10.3390/nu14194013.
3
Vitamin D-Related Genetic Variations and Nonalcoholic Fatty Liver Disease: A Systematic Review.
应对全球肥胖流行:探究维生素D在代谢综合征管理中的作用及潜在机制。
Front Nutr. 2024 Aug 9;11:1416344. doi: 10.3389/fnut.2024.1416344. eCollection 2024.
4
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
5
Exploring the interactions between metabolic dysfunction-associated fatty liver disease and micronutrients: from molecular mechanisms to clinical applications.探索代谢功能障碍相关脂肪性肝病与微量营养素之间的相互作用:从分子机制到临床应用。
Front Nutr. 2024 Mar 14;11:1344924. doi: 10.3389/fnut.2024.1344924. eCollection 2024.
6
Targeting nuclear receptors for NASH/MASH: From bench to bedside.针对非酒精性脂肪性肝炎/代谢相关脂肪性肝炎的核受体:从 bench 到 bedside。 (注:bench可理解为实验室研究阶段,bedside可理解为临床应用阶段 ,这里直接保留英文未完全意译,因为准确翻译这两个词在该语境下较难找到完全对应的精准中文表述,直接保留英文更能体现原文专业语境)
Liver Res. 2024 Mar;8(1):34-45. doi: 10.1016/j.livres.2024.03.002.
7
Association of the ESR1 (rs9340799), OLR1 (rs3736234), LIPC (rs2070895), VDR (rs2228570), and CETP (rs708272) Polymorphisms With Risk of Coronary Artery Disease in Iranian Patients.ESR1(rs9340799)、OLR1(rs3736234)、LIPC(rs2070895)、VDR(rs2228570)和 CETP(rs708272)多态性与伊朗患者冠心病风险的关联。
J Clin Lab Anal. 2024 Mar;38(6):e25026. doi: 10.1002/jcla.25026. Epub 2024 Mar 20.
8
Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.维生素 D 受体 rs3782905 和维生素 D 结合蛋白 rs7041 多态性与丙型肝炎病毒肝硬化患者肝细胞癌易感性相关。
BMC Med Genomics. 2023 Dec 8;16(1):319. doi: 10.1186/s12920-023-01749-8.
9
Advances in Molecular Medicine: Unravelling Disease Complexity and Pioneering Precision Healthcare.分子医学进展:揭示疾病复杂性与开创精准医疗
Int J Mol Sci. 2023 Sep 16;24(18):14168. doi: 10.3390/ijms241814168.
10
Vitamin D: An Overview of Gene Regulation, Ranging from Metabolism to Genomic Effects.维生素D:从代谢到基因组效应的基因调控概述
Genes (Basel). 2023 Aug 25;14(9):1691. doi: 10.3390/genes14091691.
维生素 D 相关基因变异与非酒精性脂肪性肝病:系统评价。
Int J Mol Sci. 2022 Aug 14;23(16):9122. doi: 10.3390/ijms23169122.
4
Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling.钙泊三醇通过阻断 PI3K/Akt 信号通路废除了癌细胞来源的成纤维细胞衍生的白细胞介素-8 介导的胃癌细胞对奥沙利铂的耐药性。
Acta Pharmacol Sin. 2023 Jan;44(1):178-188. doi: 10.1038/s41401-022-00927-1. Epub 2022 Jun 8.
5
Resolution of, and Risk of Incident Non-alcoholic Fatty Liver Disease With Changes in Serum 25-hydroxy Vitamin D Status.血清 25-羟维生素 D 状态变化与非酒精性脂肪性肝病发生和缓解的关系。
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3437-e3447. doi: 10.1210/clinem/dgac255.
6
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma.考虑维生素 D 对已确立的癌症(以恶性黑素瘤为例)可能产生的影响。
Pigment Cell Melanoma Res. 2022 Jul;35(4):408-424. doi: 10.1111/pcmr.13040. Epub 2022 May 11.
7
1α,25(OH)D reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells.1α,25-二羟基维生素D可逆转人细胞毒性T细胞耗竭并增强其抗肿瘤免疫。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003477.
8
Novel insight into the role of the vitamin D receptor in the development and function of the immune system.维生素 D 受体在免疫系统发育和功能中的作用的新见解。
J Steroid Biochem Mol Biol. 2022 May;219:106084. doi: 10.1016/j.jsbmb.2022.106084. Epub 2022 Feb 22.
9
Calcipotriol attenuates liver fibrosis through the inhibition of vitamin D receptor-mediated NF-κB signaling pathway.卡泊三醇通过抑制维生素 D 受体介导的 NF-κB 信号通路减轻肝纤维化。
Bioengineered. 2022 Feb;13(2):2658-2672. doi: 10.1080/21655979.2021.2024385.
10
Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet.低脂饮食喂养的脂肪特异性 VDR 缺失小鼠发生肝脂肪变性。
Endocrinology. 2022 Feb 1;163(2). doi: 10.1210/endocr/bqab249.